Investor Relations

Diagonal Bio is a Swedish biotech company that has developed a ground breaking universal technology platform for the quick and accurate detection of genetic markers in genetic material (DNA and RNA).

Background

Diagonal Bio AB is a Swedish medical technology company founded in 2020 with the vision of limiting the spread of infectious diseases by creating a user-friendly, cost-effective diagnostic platform with high accuracy. Based on its patented technology, Diagonal Bio plans to develops a diagnostic systems, PANVIRAL™, that have the potential to fulfill the vision and thereby facilitate the challenge of rapidly and accurately identifying genetic markers for infectious diseases.

Diagonal Bio’s patented technology can also be used for other purposes outside the market segment for in-vitro diagnostics, for example as a general laboratory equipment quick, accurate and cost-effective identification of genetic markers (LAMPlify^®).

Diagonal Bio’s patented technology

Diagonal Bio’s patented technology offers the same accuracy as today’s leading diagnostic method, PCR, but is not dependent on complicated logistics or large central laboratories and is therefore significantly faster and more cost-effective. With the help of the Company’s technology, today’s and future infectious diseases can be diagnosed within 10–15 minutes of sampling, in connection with a visit to, for example, a primary care unit.

Diagonal Bio’s platform technology can also be used for other purposes outside the market segment for in-vitro diagnostics, for example as a general laboratory equipment quick, accurate and cost-effective identification of genetic markers (LAMPlify^®). This, too, with the same high accuracy as today’s PCR-based techniques, but in a significantly faster, simpler and more cost-effective.

View sources

[1] Agricultural and Environmental Diagnostics Market Size (2028) (businessresearchinsights.com)

[2] Food Safety Testing Market Size Will Attain 35.6 Billion by (globenewswire.com)

[3] Infectious Disease Diagnostic Market Statistics | Forecast – 2030 (alliedmarketresearch.com)

Press Releases

2025

2025-12-11 13:50 Diagonal Bio has been declared in bankruptcy Regulatory

Diagonal Bio AB (publ), 559248-8984, Scheeletorget 1, 223 81 Lund, has December 11, 2025 been declared bankrupt by the District Court of Lund.

2025-12-11 10:45 Diagonal Bio intends to submit a formal application for bankruptcy Regulatory MAR

Today, on the 11th of December 2025, the Board of Diagonal Bio AB (publ) has decided to submit a formal application for bankruptcy to the District Court...

2025-12-01 08:30 Nomination Committee appointed for Diagonal Bio Regulatory

Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") today announces that the Nomination Committee has been appointed in preparation for the Annual...